Skip to main content
Filing year 2023

PHARE BIO INC

Boston, Massachusetts·EIN 85-1085804·NTEE H99 · Medical Research·3
Total revenue
$2.1M
Total assets
$2.6M
Total expenses
$0
Reported officers
8
Mission

PHARE BIO'S MISSION IS TO DEVELOP CRITICALLY NEEDED ANTIBIOTICS TO ADDRESS A LOOMING CRISIS IN ANTIBIOTIC RESISTANCE. USING NOVEL AI AND DEEP LEARNING APPROACHES, PHARE BIO AIMS TO RAPIDLY DISCOVER AND DEVELOP NEW CLASSES OF ANTIBIOTICS AGAINST THE DEADLIEST PATHOGENS, AND ENSURE THAT THESE THERAPIES REACH THE PATIENTS IN GREATEST NEED.

Executive compensation, broken down

Form 990 · Schedule J · 2 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
$563k
Senior Director, Business Strategies
highest compensated employee
$167k

Plus 6 unpaid individuals.

Browse compensation in Medical Research

Up 2%
from 2022

From $552k in 2022 to $563k in 2023.

$552k
2022
$563k
2023
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.